Vanguard Personalized Indexing Management’s Cellebrite CLBT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Buy	+14,207	New	+$188K	﹤0.01%	1903

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Vanguard Personalized Indexing Management's CLBT Position: Q2 2026 in Review

Vanguard Personalized Indexing Management opened a new position in Cellebrite (CLBT) in Q2 2026: 14,207 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1903 among its holdings.

201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Vanguard Personalized Indexing Management held 14,207 shares of Cellebrite worth $207K as of Q2 2026.
Cellebrite was a new Vanguard Personalized Indexing Management position in Q2 2026.
Cellebrite made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1903 holding.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.